Why Aegerion Is Worth 1,732 Times Sales
Seeking Alpha
Aegerion Pharmaceuticals Earnings Preview: Can This Streak Finally End?
Wall Street Cheat Street
2 Orphan Drugmakers With Upcoming Catalysts
Seeking Alpha
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
- AbbVie
- Achillion
- Aegerion
- Amarin
- Arena Pharmaceuticals
- AstraZeneca
- Aveo Pharmaceutical
- Biogen Idec
- Bristol-Myers Squibb
- Delcath
- Dendreon
- Depomed
- Gilead
- GSK
- Merck
- NewLink Genetics
- Raptor Pharmaceuticals
- Rigel
- Sangamo BioSciences
- Sucampo
- Titan Pharmaceuticals
- Valeant Pharmaceuticals
- Vertex Pharmaceuticals
- Vivus
- Zogenix
Aegerion stock continues to climb after full-year financials
Bizjournals.com
4 Can't-Miss Health-Care Events This Week
Motley Fool
Aegerion Pharmaceuticals Expected To Take A Hit
Seeking Alpha
Better Cancer Treatment: Partnerships and Dividends
The Motley Fool
13 Biotech Stock Predictions for 2013
TheStreet.com